Stock Pulse
UnitedHealth Group (UNH) received a positive affirmation of its "a" (Excellent) Long-Term Issuer Credit Rating from AM Best, reflecting strong financial performance and market position [1]. Despite navigating challenges in 2024, including a cyberattack and the sale of its South American business [1], [2], [15], the company exceeded $400 billion in revenue [2], [4] and experienced growth in its Optum segment [5], [15]. While Q3 2024 operating metrics were mixed and 2025 guidance was lowered [4], UNH maintains a positive outlook, driven by its strong Medicare Advantage growth [10], a favorable legal ruling [3], [5], and projected revenues approaching $450-455 billion for 2025 [2], [7]. However, ongoing regulatory scrutiny regarding Medicare billing practices [8], [9] and broader industry concerns [7] present potential risks. Multiple insider stock transactions occurred, primarily involving exercising stock options and receiving awards, but resulting in a net decrease of shares held [11], [12], [13], [14].